Shanu Modi
13PUBLICATIONS
83CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Nov 10, 2025
Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding.Wanyi Chen, Avantika Gupta, Nicholas Mai
|Oct 08, 2025
Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial.Shanu Modi, William Jacot, Hiroji Iwata
|Mar 25, 2025
Treatment patterns and outcomes in HER2-low metastatic breast cancer patients previously treated with chemotherapy: a US real-world cohort study.Shanu Modi, Suyuan Zhang, Danalyn Byng
|Aug 02, 2024
Author Correction: Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives.Antonio Marra, Sarat Chandarlapaty, Shanu Modi
|Jan 09, 2024
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives.Antonio Marra, Sarat Chandarlapaty, Shanu Modi
|Oct 18, 2022
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis.Guy Jerusalem, Yeon Hee Park, Toshinari Yamashita
Pageof 3
Frequent Collaborators
4 joint publications
Sarat Chandarlapaty
2 joint publications
Antonio Marra
2 joint publications
Toshinari Yamashita
2 joint publications
Joshua Z Drago
1 joint publications
Milan Grkovski
1 joint publications
Larry Norton
1 joint publications
Pedram Razavi
1 joint publications
Clifford A Hudis
1 joint publications
Jason S Lewis
1 joint publications
Montserrat Carrasco-Triguero
